Andere talen Zynex, Inc.

Aandelen

Beurs gesloten - Nasdaq Andere beurzen 22:00:00 01-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
11,77 ^USD	+7,29%		+4,81%	+8,08%

30/04	Transcript : Zynex, Inc., Q1 2024 Earnings Call, Apr 30, 2024
01/03	ZYNEX, INC. : RBC Capital Markets herhaalt koopadvies	ZM

Earnings Flash (ZYXI) ZYNEX Posts Q1 Revenue $46.5M, vs. Street Est of $47.7M	30/04
Zynex, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	30/04
Zynex Sets First Quarter 2024 Earnings Call	18/04
Zynex Earns Prestigious 2024 Top Workplaces USA Employer Recognition Award	02/04
Zynex Reports Fourth Quarter and Full Year 2023 Financial Results	01/03
Zynex, Inc. Provides Earnings Guidance First Quarter and Full Year 2024	29/02
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on September 11, 2023.	29/02
Tranche Update on Zynex, Inc.'s Equity Buyback Plan announced on November 1, 2023.	29/02
Zynex, Inc. announces an Equity Buyback for $20 million worth of its shares.	29/02
Earnings Flash (ZYXI) ZYNEX Reports Q4 Revenue $47.3M, vs. Street Est of $55.6M	29/02
Zynex, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023	29/02
Zynex, Inc. authorizes a Buyback Plan.	29/02
Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call	22/02
Zynex Introduces New Products	20/02
Zynex, Inc. Introduces New Products	20/02
Zynex Receives FDA Clearance for its Next Generation NMES Device	07/02
Zynex Receives US FDA Approval for Muscle Stimulation Device	06/02
Zynex, Inc. Receives FDA Clearance for its Next Generation NMES Device	06/02
Zynex Recognized in Top 25 Medical Device Companies for 2024	02/02
Zynex to Participate at the Needham Annual Growth Conference	08/01

Geen resultaten voor deze zoekopdracht